Cargando…

Pericyte protection by edaravone after tissue plasminogen activator treatment in rat cerebral ischemia

Pericytes play a pivotal role in contraction, mediating inflammation and regulation of blood flow in the brain. In this study, changes of pericytes in the neurovascular unit (NVU) were examined in relation to the effects of exogenous tissue plasminogen activator (tPA) and a free radical scavenger, e...

Descripción completa

Detalles Bibliográficos
Autores principales: Deguchi, Kentaro, Liu, Ning, Liu, Wentao, Omote, Yoshio, Kono, Syoichiro, Yunoki, Taijun, Deguchi, Shoko, Yamashita, Toru, Ikeda, Yoshio, Abe, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263311/
https://www.ncbi.nlm.nih.gov/pubmed/24938625
http://dx.doi.org/10.1002/jnr.23420
_version_ 1782348545647443968
author Deguchi, Kentaro
Liu, Ning
Liu, Wentao
Omote, Yoshio
Kono, Syoichiro
Yunoki, Taijun
Deguchi, Shoko
Yamashita, Toru
Ikeda, Yoshio
Abe, Koji
author_facet Deguchi, Kentaro
Liu, Ning
Liu, Wentao
Omote, Yoshio
Kono, Syoichiro
Yunoki, Taijun
Deguchi, Shoko
Yamashita, Toru
Ikeda, Yoshio
Abe, Koji
author_sort Deguchi, Kentaro
collection PubMed
description Pericytes play a pivotal role in contraction, mediating inflammation and regulation of blood flow in the brain. In this study, changes of pericytes in the neurovascular unit (NVU) were examined in relation to the effects of exogenous tissue plasminogen activator (tPA) and a free radical scavenger, edaravone. Immunohistochemistry and Western blot analyses showed that the overlap between platelet-derived growth factor receptor β-positive pericytes and N-acetylglucosamine oligomers (NAGO)-positive endothelial cells increased significantly at 4 days after 90 min of transient middle cerebral artery occlusion (tMCAO). The number of pericytes and the overlap with NAGO decreased with tPA but recovered with edaravone 4 days after tMCAO with proliferation. Thus, tPA treatment damaged pericytes, resulting in the detachment from astrocytes and a decrease in glial cell line-derived neurotrophic factor secretion. However, treatment with edaravone greatly improved tPA-induced damage to pericytes. The present study demonstrates that exogenous tPA strongly damages pericytes and destroys the integrity of the NVU, but edaravone treatment can greatly ameliorate such damage after acute cerebral ischemia in rats. © 2014 The Authors. Journal of Neuroscience Research Published by Wiley Periodicals, Inc.
format Online
Article
Text
id pubmed-4263311
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BlackWell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-42633112014-12-15 Pericyte protection by edaravone after tissue plasminogen activator treatment in rat cerebral ischemia Deguchi, Kentaro Liu, Ning Liu, Wentao Omote, Yoshio Kono, Syoichiro Yunoki, Taijun Deguchi, Shoko Yamashita, Toru Ikeda, Yoshio Abe, Koji J Neurosci Res Research Articles Pericytes play a pivotal role in contraction, mediating inflammation and regulation of blood flow in the brain. In this study, changes of pericytes in the neurovascular unit (NVU) were examined in relation to the effects of exogenous tissue plasminogen activator (tPA) and a free radical scavenger, edaravone. Immunohistochemistry and Western blot analyses showed that the overlap between platelet-derived growth factor receptor β-positive pericytes and N-acetylglucosamine oligomers (NAGO)-positive endothelial cells increased significantly at 4 days after 90 min of transient middle cerebral artery occlusion (tMCAO). The number of pericytes and the overlap with NAGO decreased with tPA but recovered with edaravone 4 days after tMCAO with proliferation. Thus, tPA treatment damaged pericytes, resulting in the detachment from astrocytes and a decrease in glial cell line-derived neurotrophic factor secretion. However, treatment with edaravone greatly improved tPA-induced damage to pericytes. The present study demonstrates that exogenous tPA strongly damages pericytes and destroys the integrity of the NVU, but edaravone treatment can greatly ameliorate such damage after acute cerebral ischemia in rats. © 2014 The Authors. Journal of Neuroscience Research Published by Wiley Periodicals, Inc. BlackWell Publishing Ltd 2014-11 2014-06-17 /pmc/articles/PMC4263311/ /pubmed/24938625 http://dx.doi.org/10.1002/jnr.23420 Text en Copyright © 2014 The Authors. Journal of Neuroscience Research Published by Wiley Periodicals, Inc. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Deguchi, Kentaro
Liu, Ning
Liu, Wentao
Omote, Yoshio
Kono, Syoichiro
Yunoki, Taijun
Deguchi, Shoko
Yamashita, Toru
Ikeda, Yoshio
Abe, Koji
Pericyte protection by edaravone after tissue plasminogen activator treatment in rat cerebral ischemia
title Pericyte protection by edaravone after tissue plasminogen activator treatment in rat cerebral ischemia
title_full Pericyte protection by edaravone after tissue plasminogen activator treatment in rat cerebral ischemia
title_fullStr Pericyte protection by edaravone after tissue plasminogen activator treatment in rat cerebral ischemia
title_full_unstemmed Pericyte protection by edaravone after tissue plasminogen activator treatment in rat cerebral ischemia
title_short Pericyte protection by edaravone after tissue plasminogen activator treatment in rat cerebral ischemia
title_sort pericyte protection by edaravone after tissue plasminogen activator treatment in rat cerebral ischemia
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263311/
https://www.ncbi.nlm.nih.gov/pubmed/24938625
http://dx.doi.org/10.1002/jnr.23420
work_keys_str_mv AT deguchikentaro pericyteprotectionbyedaravoneaftertissueplasminogenactivatortreatmentinratcerebralischemia
AT liuning pericyteprotectionbyedaravoneaftertissueplasminogenactivatortreatmentinratcerebralischemia
AT liuwentao pericyteprotectionbyedaravoneaftertissueplasminogenactivatortreatmentinratcerebralischemia
AT omoteyoshio pericyteprotectionbyedaravoneaftertissueplasminogenactivatortreatmentinratcerebralischemia
AT konosyoichiro pericyteprotectionbyedaravoneaftertissueplasminogenactivatortreatmentinratcerebralischemia
AT yunokitaijun pericyteprotectionbyedaravoneaftertissueplasminogenactivatortreatmentinratcerebralischemia
AT deguchishoko pericyteprotectionbyedaravoneaftertissueplasminogenactivatortreatmentinratcerebralischemia
AT yamashitatoru pericyteprotectionbyedaravoneaftertissueplasminogenactivatortreatmentinratcerebralischemia
AT ikedayoshio pericyteprotectionbyedaravoneaftertissueplasminogenactivatortreatmentinratcerebralischemia
AT abekoji pericyteprotectionbyedaravoneaftertissueplasminogenactivatortreatmentinratcerebralischemia